iSpecimen Inc. (ISPC) Form 8-K — Sep 10, 2026
iSpecimen Inc. (ISPC) disclosed it received a Nasdaq deficiency letter dated September 8, 2026, and was granted an extension until November 25, 2026 to regain compliance with Listing Rule 5550(b), which requires at least $2.5 million in stockholders' equity. The company has been non-compliant since May 29, 2026, and submitted three compliance plans (July 13, August 6, and September 4) built around a ~$2.5 million private placement that closed May 11, 2026 and a planned ~$5 million best-efforts public offering.
Key figures
- Compliance deadline
- November 25, 2026
- Projected stockholders equity
- approximately $5.1 million through June 30, 2027
- Initial deficiency notice date
- May 29, 2026
- Private placement gross proceeds
- approximately $2.5 million (closed May 11, 2026)
- Alternative net income requirement
- 500000
- Alternative market value requirement
- 35000000
- Planned public offering gross proceeds
- approximately $5 million (best-efforts)
- Minimum stockholders equity requirement
- 2500000
Price after filing
Close on the filing date to close N calendar days later (from $1.55). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.